Background Image
Table of Contents Table of Contents
Previous Page  29 / 60 Next Page
Information
Show Menu
Previous Page 29 / 60 Next Page
Page Background

29

Scientific programme

Friday, 29 May 2015

P-15-007 Psycho-education for ADHD medication

initiation for children and adolescents in

a London borough: An innovation and

improvement project

O. Malomo, United Kingdom

O. Moghraby

P-15-008 LINK: The adult Attention-Deficit/Hyper­

activity Disorder programme (ADHD):

Connecting-educating-advancing (Part II)

L. Klassen, Canada

A. Fallu

P-15-009 A clinical audit of transitional care in ado-

lescents with ADHD at Blakesley Centre

CAMHS

J. Holmes, United Kingdom

E. Loh

P-15-010 Medication non-adherence, symptom

worsening and relapse, and their impli-

cations for health-related quality of life

in the treatment of Attention-Deficit/

Hyperactivity Disorder(ADHD) in Non-

Western countries

J. Hong, United Kingdom

D. Novick, T. Treuer, W. Montgomery, J. M. Haro

P-15-012 Mental health of parents of children with

Attention-Deficit/Hyperactivity Disorder

in comparison with parents of children

with other developmental disabilities

T. Takamura, Japan

P-16

Guided Poster Tour

16:00–17:30

Hall 2 – Poster Area

Basic science / genetics / experimental models

Chair:

B. Franke, The Netherlands

P-16-001 Which parameters differ in the gait of

children with ADHD?

H. Naruse, Japan

C. Yatsuga, T. Fujisawa, H. Kumazaki, S. Ta­

kiguchi, H. Matsuo, M. Kubota, S. Shimada,

d. Saito, H. Kosaka, A. Tomoda

P-16-002 No association of ADHD candidate SNPs

with Parkinson’s disease

J. Geissler, Germany

M. Romanos, M. Gerlach

P-16-003 Association between genetic variants of

NET1 and emotional lability of ADHD

independent of ODD diagnosis or ODD

symptoms

L. Liu, People‘s Republic of China

L. Sun, X. Yu, H. Li, L. Yang, Q. Qian, Y. Wang

P-16-004 Dopamine transporter (DAT1)and do-

pamine receptor (DRD4) genotype and

response to methylphenidate and atom-

oxetine

M. Stein, USA

T. Hildebrandt, E. Cook Jr, E. Olson,

I. Waldman, J. Newcorn

P-16-005 Hyper-locomotor activity in mice lacking

in an enzyme synthesizing chondroitin

sulfate as an animal model of ADHD

M. Igarashi, Japan

N. Yoshioka, K. Takeuchi, K. Takao, T. Mi­

yakawa

P-16-006 Shared prefrontal cortical gene expression

profiles in “impulsive“ SHR and Wistar

rats: Effects of atomoxetine

J. B. de La Pena, Republic of Korea

H. J. Kim, I. dela Pena, C. Y. Shin, J. H. Cheong

P-16-007 Unravelling the effect of methylphenidate

on human brain endothelial cells

V. Santos, Portugal

R. Socodato, C. Portugal, M. Rito, M. Barbosa,

P.-O. Couraud, I. A. Romero, B. Weksler, R.

Minshall, C. Fontes-Ribeiro, T. Summavielle,

J. B. Relvas, A. P. Silva

P-16-008 Expressional profile in fibroblasts of PARK2

CNV carriers with adult ADHD

S. Kittel-Schneider, Germany

D. Gersic, M. Frank, C. Lorenz, J. Auer, K.-P.

Lesch, S. Winkler, S. Klebe, A. Reif

P-16-009 Transcranial direct current stimulation im­

proves short-term memory in an animal

model of Attention-Deficit/Hyperactivity

Disorder

D. Teixeira Leffa, Brazil

V. Scarabelot, A. de Souza, L. Fernandes

Medeiros, E. Horácio Grevet, D. Onofre

Gomes de Souza, L. A. Paim Rohde, I. Lucena

da Silva Torres, C. de Oliveira